CAPR
Capricor Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.40
+1.29%Leverage
- Debt / equity
- 0.37x
- Net debt / equity
- 0.28x
- Debt / assets
- 0.25x
- Debt / EBITDA
- 0.08x
- Net debt / EBITDA
- 0.06x
Liquidity & coverage
- Current ratio
- 7.35x
- Quick ratio
- 7.35x
- Cash ratio
- 7.22x
- Interest coverage
- -44.38x
- EBITDA / interest
- 385.43x
- Working capital
- $209.2M
Cash & dividend
- FCF / debt
- -1.43x
- Cash flow / debt
- -1.14x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026